288 related articles for article (PubMed ID: 12923007)
1. Inflammatory and thrombotic mechanisms in coronary atherosclerosis.
Tousoulis D; Davies G; Stefanadis C; Toutouzas P; Ambrose JA
Heart; 2003 Sep; 89(9):993-7. PubMed ID: 12923007
[TBL] [Abstract][Full Text] [Related]
2. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes.
Madjid M; Vela D; Khalili-Tabrizi H; Casscells SW; Litovsky S
Tex Heart Inst J; 2007; 34(1):11-8. PubMed ID: 17420787
[TBL] [Abstract][Full Text] [Related]
3. Targeting the inflammatory component in atherosclerotic lesions vulnerable to rupture.
Hartung D; Narula J
Z Kardiol; 2004 Feb; 93(2):97-102. PubMed ID: 14963674
[TBL] [Abstract][Full Text] [Related]
4. Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.
da Silva AR; Fraga-Silva RA; Stergiopulos N; Montecucco F; Mach F
Eur J Clin Invest; 2015 Mar; 45(3):274-87. PubMed ID: 25586671
[TBL] [Abstract][Full Text] [Related]
5. Association of coronary plaque rupture and atherosclerotic inflammation.
Boyle JJ
J Pathol; 1997 Jan; 181(1):93-9. PubMed ID: 9072009
[TBL] [Abstract][Full Text] [Related]
6. Update on acute coronary syndromes: the pathologists' view.
Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocytes and monocytes in atherogenesis.
Schmitz G; Herr AS; Rothe G
Herz; 1998 May; 23(3):168-77. PubMed ID: 9646098
[TBL] [Abstract][Full Text] [Related]
8. Immune checkpoint inhibition alters the inflammatory cell composition of human coronary artery atherosclerosis.
Newman JL; Stone JR
Cardiovasc Pathol; 2019; 43():107148. PubMed ID: 31518915
[TBL] [Abstract][Full Text] [Related]
9. In-situ analysis of mast cells and dendritic cells in coronary atherosclerosis in chronic kidney disease (CKD).
Wachter DL; Neureiter D; Câmpean V; Hilgers KF; Büttner-Herold M; Daniel C; Benz K; Amann K
Histol Histopathol; 2018 Aug; 33(8):871-886. PubMed ID: 29616745
[TBL] [Abstract][Full Text] [Related]
10. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.
Farb A; Burke AP; Tang AL; Liang TY; Mannan P; Smialek J; Virmani R
Circulation; 1996 Apr; 93(7):1354-63. PubMed ID: 8641024
[TBL] [Abstract][Full Text] [Related]
11. Role of thrombosis in atherosclerosis and its complications.
Falk E; Fernández-Ortiz A
Am J Cardiol; 1995 Feb; 75(6):3B-11B. PubMed ID: 7863969
[TBL] [Abstract][Full Text] [Related]
12. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque.
Hu CL; Xiang JZ; Hu FF; Huang CX
Med Hypotheses; 2007; 68(6):1262-4. PubMed ID: 17161549
[TBL] [Abstract][Full Text] [Related]
13. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and immunological nature of atherosclerosis.
Watanabe T; Haraoka S; Shimokama T
Int J Cardiol; 1996 Aug; 54 Suppl():S51-60. PubMed ID: 9119527
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis.
Monaco C; Paleolog E
Cardiovasc Res; 2004 Mar; 61(4):671-82. PubMed ID: 14985064
[TBL] [Abstract][Full Text] [Related]
16. Present concepts of coronary atherosclerosis-thrombosis, therapeutic implications and perspectives.
Fuster V
Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():41-7. PubMed ID: 9515113
[TBL] [Abstract][Full Text] [Related]
17. [Should hemostatic factors be considered in the prevention of cardiovascular disease?].
Musiał J; Duplaga M
Pol Tyg Lek; 1993 Aug 2-16; 48(31-33):699-702. PubMed ID: 7971494
[TBL] [Abstract][Full Text] [Related]
18. Endothelial function and inflammation in coronary artery disease.
Tousoulis D; Charakida M; Stefanadis C
Postgrad Med J; 2008 Jul; 84(993):368-71. PubMed ID: 18716016
[TBL] [Abstract][Full Text] [Related]
19. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.
van der Wal AC; Becker AE; van der Loos CM; Das PK
Circulation; 1994 Jan; 89(1):36-44. PubMed ID: 8281670
[TBL] [Abstract][Full Text] [Related]
20. Biologic aspects of vulnerable plaque.
Corti R; Badimon JJ
Curr Opin Cardiol; 2002 Nov; 17(6):616-25. PubMed ID: 12466704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
